<DOC>
	<DOCNO>NCT01543373</DOCNO>
	<brief_summary>The purpose study demonstrate non-inferiority Cre8 ( CID ) Drug Eluting Stent , study 3 month implant , compare Vision/Multilink8 Bare Metal Stent ( Abbott ) study 1 month , term neointimal coverage , determine Optical Coherence Tomography ( OCT ) , percentage cross-sections RUTTS ( Ratio Uncovered Total Stent Struts Per Cross Section ) score ≤ 0.3 .</brief_summary>
	<brief_title>Optical Coherence Tomography Comparison Neointimal Coverage Between CRE8 DES BMS</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Age &gt; 18 year ; Patients symptoms stable unstable angina and/or presence positive functional test ischemia ; Patient eligible percutaneous coronary intervention ( PCI ) acceptable candidate surgical revascularization ( CABG ) ; Left ventricular ejection fraction &gt; 30 % ; Patients present least two vessel disease require stag procedure within 3 month , accord operator judgement ; Target denovo lesion ; Target lesion locate target vessel diameter range 2.5 3.75 mm ; Target lesion diameter stenosis &gt; 50 % &lt; 100 % visual estimate , TIMI flow &gt; =1 ; Discrete lesion length range 13 25 mm ; The target lesion must appropriately cover ( margin 2.5 mm side stent ) one study stent ( Cre8 Vision/Multilink 8 ) , accord randomization arm ; Patient inform nature study agree provision provide write informed consent approve Ethical Committee respective clinical site . Female childbearing potential lactating ; Patient present acute myocardial infarction ST elevation ; Known allergy antiplatelets , anticoagulant , contrast medium , sirolimus cobalt chromium ; Cerebrovascular accident within past 6 month ; Acute chronic renal dysfunction ( define creatinine great 2.0 mg/dl ) ; Thrombocytopenia ( platelet count le 100,000/mm³ ) ; Known bleed hypercoagulable disorder ; Currently immunosuppressant therapy ; Comorbidities could interfere completion study procedure , life expectancy le 1 year ; Participating another investigational drug device trial complete primary endpoint would interfere endpoint study ; Patient underwent target vessel revascularization DES ; Heavily calcify vessel and/or lesion successfully predilated imaged OCT Target lesion locate supplied arterial venous bypass graft ; Lesion locate distally , difficult image OCT ; Lesion locate angulate ( &gt; 70° ) , sharp takeoff vessel ; Target lesion involve bifurcation side branch ≥2.0 mm diameter ; Target lesion locate leave main stem ; Ostial lesion location ; Target lesion TIMI 0 flow ; Target vessel angiographically visible thrombus unsuitable proper stent delivery deployment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Tissue coverage</keyword>
	<keyword>DES</keyword>
</DOC>